Efficacy and safety of Cerebrolysin in patients with hemorrhagic stroke

The purpose of the study was to investigate the efficacy and safety of Cerebrolysin in patients with hemorrhagic stroke. The primary objective of this trial was to assess the clinical efficacy and safety of a 10–days course of therapy with a daily administration of Cerebrolysin (50 mL Ⅳ per day). Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Bajenaru, O, Tiu, C, Moessler, H, Antochi, F, Muresanu, D, Popescu, BO, Novak, P
Formato: Texto
Lenguaje:English
Publicado: Carol Davila University Press 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3019043/
https://www.ncbi.nlm.nih.gov/pubmed/20968198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3019043/
https://www.ncbi.nlm.nih.gov/pubmed/20968198

Ejemplares similares